Graft Polymer (UK) PLC New Corporate Presentation
September 20 2022 - 1:00AM
RNS Non-Regulatory
TIDMGPL
Graft Polymer (UK) PLC
20 September 2022
20 September 2022
Graft Polymer (UK) Plc
("Graft Polymer", the "Company", and together with its
subsidiaries, the "Group")
New Corporate Presentation
Graft Polymer (UK) Plc (LSE: GPL), a business focused on the
development and commercial production of polymer modification,
biological supplements, and nano-drug delivery systems, is pleased
to announce that an updated corporate presentation is now available
on its website: https://graftpolymer.com/ .
**ENDS**
For more information, please visit https://www.graftpolymer.com or contact:
Graft Polymer (UK) Plc via St Brides Partners
Roby Zomer, Chairman
Yifat Steuer, CFO
Turner Pope Investments (Broker) +44 20 3657 0050
James Pope
Andy Thacker
St Brides Partners (Public Relations)
Catherine Leftley graftpolymer@stbridespartners.co.uk
Ana Ribeiro
Max Bennett
About Graft Polymer
Graft Polymer is a London Stock Exchange listed company (GPL.L)
with a cutting-edge, cash-flow positive, research and development
(R&D) and manufacturing facility based in Slovenia which has
already introduced more than 50 products to the market. The core
business of the Group comprises polymer modification and drug
delivery system developments. The Group has developed a proprietary
set of polymer modification technologies which uses recycled raw
materials and a closed loop system to reduce waste. Graft Polymer's
technology can improve existing products and processing
methodologies by enhancing performance, simplifying manufacturing,
reducing material consumption, widening the choice of feedstocks,
and reducing costs.
Graft Polymer has three divisions: the first division focusses
on polymer modification; the second is GraftBio which develops IP
for Bio/Pharma applications (including a drug delivery system to
support and provide solutions to the market, which had been heavily
impacted by the COVID-19 pandemic); and the third is the Group's
food supplement division. A significant milestone was reached in
May 2022 when the Slovenian manufacturing facility was granted a
Hazard Analysis and Critical Control Point (HACCP) Certificate. The
HACCP Certificate allows it to enter the lucrative
Business-to-Consumer market and commercialise its IP for bio/pharma
applications, developing active pharmaceutical ingredients and drug
delivery platforms for use in the food supplement market, thereby
introducing a further revenue stream to its business.
Environment, Social and Governance is at the forefront of the
Group's strategy and the facility in Slovenia has been granted ISO
14001 accreditation in recognition of the environmental management
systems in place to reduce waste. Graft Polymer only uses REACH and
ROHS certificated raw materials instead of toxic raw materials, and
its extensive R&D programme has also developed specialised
recycling polymer additives which increases the strength of
recycled blends and plastic products whilst also reducing plastic
waste by between 40 and 50 per cent.
Graft Polymer is well funded and debt free.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFLFLFAEIDLIF
(END) Dow Jones Newswires
September 20, 2022 02:00 ET (06:00 GMT)
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From Apr 2024 to May 2024
Graft Polymer (uk) (LSE:GPL)
Historical Stock Chart
From May 2023 to May 2024